Heart of the Matter: Cardiac Toxicity

Patients should be aware of possible cardiac toxicities & what to do about them.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
In 2002, Katharine Ray, a 27-year survivor of Hodgkin lymphoma, wanted work "that mattered" when she joined the staff of The Minnie Pearl Cancer Foundation (now PearlPoint Cancer Support) in Nashville, Tenn. A year later, at age 42, she received a diagnosis of stage 1 breast cancer, probably a result of radiation treatments she received when she was 14.

The diagnosis served as an important point of demarcation for Ray, who had never really processed what happened to her as a teenager.

"I had been there a year and was just beginning to understand my chances for a second cancer, and then it happens, and it's reality," she says. "I began looking past the breast cancer treatment & began gathering all the information I could find for late effects from the Hodgkin treatment going forward."

Ray took her research on possible late effects and, with her oncologist, made a plan for how she should be followed in the areas where she could be at risk.

She had noticed that at times her heart beat rapidly, and she was getting easily winded while climbing stairs or taking walks that involved any kind of incline. All her test results were normal, but in 2012 she decided to see a cardiologist who would understand what to look for when considering her medical history. She didn’t have to look far.

Across town from PearlPoint, cardiologist Daniel Lenihan directed the clinical research program at Vanderbilt University Medical Center in the division of cardiovascular medicine. In 2009, he cofounded the International Cardioncology Society (ICOS) with a goal to promote training and study in the field of cardiac implications of cancer treatments.

Lenihan is one of a growing number of cardiologists who focuses on cancer patients. This partnership of cardiologists and oncologists combines their knowledge to protect the hearts of people undergoing cancer treatment—patients such as Katharine Ray.

Heart Hazards

People who have survived cancer are at risk for a number of cardiac long-term and late effects linked to radiation and chemotherapy treatments, ranging from high blood pressure on one end of the spectrum to congestive heart failure on the other.

Radiation treatment can cause a thickening of the inner lining of the artery, known as atherosclerosis, which can cause blood clots and other problems associated with narrowed arteries and reduced blood flow. Chemotherapy and radiation may also cause structural heart problems, such as cardiomyopathy (weakening of the heart muscle), valvular heart disease and valvular degeneration, as well as pericardial effusion (a buildup of fluid around the heart) or pericardial constriction (an abnormal thickening of the lining enclosing the heart).

In addition, not only is radiation for Hodgkin lymphoma at a young age now recognized as a risk factor for later heart problems but also for breast cancer. In the past two decades, as these issues have come to light, patients with Hodgkin disease, as well as others receiving radiation treatments, now receive lower total doses of radiation, smaller doses given more often (hyperfractionation), cardiac shielding and education about following a heart-healthy lifestyle.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
CURE wants to hear from you! We are inviting you to Share Your Story with the readers of CURE. Submit your personal experience with cancer by visiting Share Your Story
Not yet receiving CURE in your mailbox? Sign up to receive CURE Magazine by visiting GetCureNow.com